Study S002314

Glucagon-Like Peptide-1 Agonist Effects on Energy Balance in Hypothalamic Obesity

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record Study Protocol and Statistical Analysis Plan (PDF)

Registration

Registration: NCT02664441
Acronym: ECHO
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: QUADRUPLE
Status: COMPLETED
Enrollment: 42
Start: 2016-03
Primary completion: 2020-03-16
Lead sponsor: Seattle Children's Hospital
Conditions: Hypothalamic Obesity
Interventions: DRUG:Exenatide; DRUG:placebo
Results posted: TRUE
Individual participant data sharing: NO

Registered primary outcomes

Percent Change of Body Mass Index (BMI) as Calculated by the Formula: Body Weight in kg Divided by Height in Meters². [From baseline to 36 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.